ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750227 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750227; 2) Community: the network communities that were significantly associated with the response to NSC 750227; 3) Molecule: the relationships between components within communities and NSC 750227; 4) MDR: the compounds that were significantly associated with the NSC 750227.

NSC Compound Enrichment Correlation
NSC 682815 12H-7,11-Nitrilo-6H,20H-dibenzo[b,m][1,15,5,8,11] dioxatriazacyclodocosine, 21,22,23,24-tetrahydro- (9CI) 0.011234153078014 0.079506671
NSC 331935 CHALCONE ANALOG 0.0112341530780143 0.21074431
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0112341530780143 -0.027098035
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0112341530780143 -0.30866236
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0112341530780143 -0.021765334
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0130238833303634 0.18290657
NSC 11240 Aizen Victoria Blue BOH 0.0130238833303634 -0.0086982621
NSC 134727 MITOMYCIN C 0.0130238833303634 0.17342239
NSC 1797 o-Aato-amidoazotoluol(German) 0.0130238833303634 0.38868656
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0130238833303634 0.20628476
Total:54  Current:12    [First] [Prev] [Next] [Last]